Not exact matches
The woman's tumour had a genetic rearrangement that produced a misshapen version of the
ALK protein,
so her doctors first administered the drug crizotinib, which inhibits the action of
ALK.
Not all lung cancers are linked to
ALK mutations,
so the drug crizotinib, which inhibits the mutant enzyme, is prescribed only for that small subgroup of lung cancer patients.
So, AST, ALT, there's other ones like
ALK PHOS, LDH, GGT, these are all enzymes.